There was a complaint of a questionable elecsys ft4 iii assay result for 1 patient tested with cobas e801 module serial number (b)(4).The questionable result was reported outside the laboratory.The result was reported to the physician.The customer repeated the patient¿s sample on a wako accuraseed.A request was made for additional investigation as the e801 generated a low result and the accuraseed fell within the normal reference range.The patient¿s initial result on the e801 was 0.75 ng/dl; the repeat on the accuraseed was 0.98 ng/dl.The patient's sample was submitted for further investigation where discrepant ft4 results were also identified between the customer's e801 module, an e801 module used at the investigation site, and the abbott architect method.Please see the attached data for details.
|
The investigation found that a general reagent issue can most likely be excluded.An interfering factor can be excluded.In the case of differences in the values generated with the different analyzers, assays from different vendors can generate different values.This relates to the overall setups of the assays, the antibodies used, differences in reference materials/methods, and the standardization methodology used.The investigation did not identify a product problem.
|